Chronic kidney disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Chronic kidney disease diagnosed by renal function examination as stage 3 or above CKD3; 2. Aged 18-80 years; 3. BUN >= 8.9 mmol/L; 4. The patients had not taken aldeoxystarch capsule before enrollment or had stopped taking aldeoxystarch capsule 2 weeks before enrollment; 5. Patients voluntarily participated in the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Dyspepsia, acute and chronic gastroenteritis, reflux esophagitis, diarrhea of unknown cause; 2. Anorexia, ulcerative colitis, gastrointestinal tumor; 3. Intestinal obstruction; 4. Cirrhosis, esophageal varices, gastrointestinal bleeding; 5. Patients with acute cardiac insufficiency; 6. Allergic to aldoxystarch or urine duqing granules; 7. Subjects who are unable or unwilling to use adequate contraception during breastfeeding, pregnancy and study (including men); 8. Participating in another clinical investigator; 9. Patients considered unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Renal function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Electrolyte;Calcium phosphate magnesium;Blood sugar;Blood fat;Routine urine;Routine blood;Serum iron;Transferrin; | — |
Countries
China
Contacts
The Second Hospital of Tianjin Medical University